TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
IFRX

InflaRx N.V.

Healthcare · Biotechnology

1.90$ -2.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

InflaRx N.V. (IFRX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -34 million EUR. Tick rows to compare them in a chart.

All figures in millions of EUR.

Tick rows to compare them in a chart (up to 4)

Cash Flow IFRX
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-3.3 -5.0 -12 -24 -43 -37 -40 -34 -38 -49 -34
0.0 0.0 0.1 0.2 0.7 0.7 0.7 0.6 0.6 0.5 0.4
0.2 0.9 4.6 12 6.8 1.1 4.3 6.0 3.4 4.1 4.4
1.2 2.7 9.4 6.3 6.0 2.1 3.5 – – – –
0.3 1.2 2.6 1.8 -2.3 -5.3 1.5 -9.8 1.0 -2.3 4.7
0.0 0.1 0.1 0.8 0.6 0.1 0.0 0.2 0.1 0.0 0.1
0.0 -0.1 -0.2 -99 20 21 -26 19 -18 52 3.1
0.0 0.0 0.0 0.0 – – – – – – –
89,458,500,057 31 118 53 0.0 – – – – – –
0.0 -0.3 -0.3 -0.3 -0.3 -0.4 -0.4 -0.4 -0.4 -0.4 -0.4
70 31 109 50 -0.3 9.2 62 1.9 53 0.4 32
-3.3 26 94 -68 -22 -7.2 0.3 -10.0 -3.5 5.6 -0.2
-3.3 -5.0 -12 -25 -44 -37 -40 -34 -38 -49 -34

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?